Elsevier

Clinical Radiology

Volume 60, Issue 12, December 2005, Pages 1300-1305
Clinical Radiology

Imaging meningiomas: Is there a need for post-contrast FLAIR?

https://doi.org/10.1016/j.crad.2005.07.005Get rights and content

AIM

The aim of this study was to compare post-contrast fluid-attenuated inversion recovery (FLAIR) imaging with post-contrast T1-weighted images (T1WI) in depicting meningiomas.

MATERIALS AND METHODS

Twenty-nine patients with 46 meningiomas were included in this study. FLAIR and T1WI were obtained before and after intravenous administration of gadopentetate dimeglumine. The contrast enhancement degree, contrast enhancement pattern, lesion conspicuity, and the detection of the dural sign were compared between post-contrast FLAIR images and post-contrast T1WI.

RESULTS

The enhencement degree on FLAIR was equal or less than T1WI for all meningiomas. Among 46 meningiomas 38 (83%) enhanced homogeneously and eight (17%) inhomogeneously on T1WI. On contrast-enhanced FLAIR images, of the total 46 meningiomas 22 (48%) enhanced homogeneously, eight (17%) inhomogeneously, whereas 14 (30%) meningiomas showed a peripheral rim enhancement not observed on T1WI. Two (5%) meningiomas showed no contrast enhancement on post-contrast FLAIR images. Among the 14 meningiomas showing rim enhancement using FLAIR imaging, 12 (85%) were measured to be 2 cm or more in diameter. A dural tail sign was found in 16 (35%) and 23 (50%) meningiomas on post-contrast T1WI and FLAIR images, respectively.

CONCLUSION

In contrast to other extra-axial diseases, post-contrast FLAIR sequence was not found to be a valuable adjunct to contrast-enhanced T1WI in the depiction of meningiomas.

Introduction

Fluid-attenuated inversion recovery (FLAIR) sequence has an inversion time that effectively nulls signals from the cerebrospinal fluid (CSF) with a long echo time (TE) that produces T2 weighting. The FLAIR technique has also a mild T1 weighted contrast, which is responsible for the observation of contrast enhancement on these heavily T2-weighted images.1 Recently, attempts have been made to use the T1 contrast of FLAIR images for gadolinium-enhanced brain magnetic resonance imaging (MRI). FLAIR imaging after contrast medium injection has been shown to be an efficacious method in the detection of various intra and extra-axial brain lesions, but especially in the delineation of meningeal lesions including meningoencephalitis and leptomeningeal metastases.2, 3, 4, 5, 6, 7, 8 The purpose of the present study was to evaluate contrast-enhanced FLAIR imaging in depicting meningiomas and to compare it with post-contrast T1-weighted images (T1WI).

Section snippets

Materials and methods

Twenty-nine patients (20 women, nine men; mean age 36 years; age range 17–73 years) with 46 meningiomas were included in this prospective study. The distribution of meningiomas per patient ranged between one to nine. Institutional review board approval and informed consent from each patient were obtained. All examinations were performed on a 1.0 T MRI machine. Axial FLAIR and T1-weighted spin-echo images were obtained before and after intravenous administration of 0.1 mmol/kg gadopentetate

Results

Seven of the 46 meningiomas were infratentorial and the remaining 39 were supratentorial in location. The size of meningiomas ranged from 7–50 mm (mean 20.1 mm). Eight meningiomas had an equal, whereas 38 had a lesser degree of contrast enhancement using FLAIR imaging compared with T1WI. None of the meningiomas showed superior contrast enhancement on FLAIR imaging (Table 1). The contrast enhancement degree did not differ in terms of which sequence was performed first or second after

Discussion

Gadopentetate dimeglumine is frequently used as an intravenous contrast agent in order to improve lesion detection and characterization in cranial MRI. Although it shortens both the T1 and T2 relaxation times of the tissues in which it accumulates, the T1 shortening is the prominent effect at commonly used doses. Therefore, T1 weighted spin-echo sequences are routinely used for gadolinium-enhanced MRI, and accepted as the gold standard in the detection and characterization of brain lesions.2, 6

References (13)

  • M. Essig et al.

    Cerebral gliomas and metastases: Assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging

    Radiology

    (1999)
  • V.P. Mathews et al.

    Brain: Gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging

    Radiology

    (1999)
  • K. Tsuchiya et al.

    FLAIR MR imaging for diagnosing intracranial meningeal carcinomatosis

    AJR Am J Roentgenol

    (2001)
  • P.D. Griffiths et al.

    Contrast-enhanced fluid-attenuated inversion-recovery imaging for leptomeningeal disease in children

    AJNR Am J Neuroradiol

    (2003)
  • M. Essig et al.

    Fluid-attenuated inversion-recovery MR imaging of gliomatosis cerebri

    Eur Radiol

    (2001)
  • M. Essig et al.

    Postoperative fluid-attenuated inversion-recovery MR imaging of cerebral gliomas: Initial results

    Eur Radiol

    (2001)
There are more references available in the full text version of this article.

Cited by (10)

View all citing articles on Scopus

Presented as a scientific poster at the ASNR 2004, Seattle, USA.

View full text